Trial Profile
Neoadjuvant chemotherpy with gemcitabine and oral S-1for pancreatic cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Jul 2016
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- 08 Jul 2013 New trial record